FLK-1+ cells derived from mouse fetal liver could differentiate into endothelial cells and smooth muscle cells.
- Author:
Cheng-Hao JIN
1
;
Yoshikazu YONEMITSU
;
Wei-Rong DING
;
Katsuo SUEISHI
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Cell Differentiation; Cells, Cultured; Fetus; cytology; Male; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; cytology; metabolism; Stem Cells; cytology; metabolism; Vascular Endothelial Growth Factor Receptor-2; metabolism
- From: Chinese Journal of Cardiology 2010;38(12):1108-1112
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo characterize the differential and proliferative activities of FLK-1(+) cells derived from mouse fetal liver.
METHODThe FLK-1(+) fraction were enriched from the fetal liver using immunomagnetic method and their differential and proliferative activities were examined in culture medium and in vivo via transplantation of FLK-1(+) cells into the inferior pole of the spleen of nine-week-old male C57 BL/6 mice after two-thirds hepatectomy.
RESULTSIn response to growth factors, FLK-1(+) cells expressed typical lineage-specific markers for vascular endothelial cells, smooth muscle cells. Intrahepatic implantation of FLK-1(+) cells resulted in the formation of blood vessels in the fibrous capsule of partially hepatectomized liver.
CONCLUSIONThese results indicate that FLK-1(+) cells derived from mouse fetal liver could differentiate into endothelial cells and smooth muscle cells and they may serve as potential stem cells for clinical cell-based therapy.